Topics
Podcast
Magazine
Popular Tags
More
To save money and increase quality of care for Medicare patients, the government is considering denying payment to hospitals for certain procedures.
Some drugs lend extreme wakefulness and focus—but are the enhancements worth the risks?
Medicina Curiosa, the first English-language medical journal, mixed the technical with the practical.
Paul A. Offit, an infectious disease specialist, discusses the costs of not vaccinating children for fear of autism.
These glasses offer a low-tech, low-cost, no-doctor solution for poor eyesight.
Synthetic biologists go far beyond genetic engineers, creating cellular computers, microbial drug factories and cancer-hunting bacteria.
Using natural language processing and other advanced search tools, bioinformatics experts are mining patient files—and striking paydirt.
Therapies that focus on tumors’ key proteins have had miraculous but often short-lived effects. New strategies could extend their usefulness.
In an excerpt from his novel Cutting for Stone, Abraham Verghese examines the importance of words of comfort.
Michael G. Fitzsimons, head of the drug-testing program at the Massachusetts General Hospital’s Department of Anesthesia and Critical Care, discusses preventing fallout from addicted physicians.
No Articles Found.
We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our Privacy Policy.
